Dr. Xu has been a full professor at Shanghai University of Medicine and Health Sciences for several years. He has contributed to many areas of clinical immunological research, including early detection of SARS fingerprint using immune-mass-spectrometry in 2003, special diagnosis in early stage of cancer, COVID-19 severity and mortality associated with the decrease in CD4, CD8 and B cells. He is the inventor of “a method for detection of severe COVID-19 caused by co-infection with influenza A and B viruses”. He received his PhD from the Cornell University. He is the Secretary General of Global Immunity Surveillance Alliance & a national expert in China and recipient of numerous awards and honors.
Title : Interpretation of non-responders to SARS CoV 2 vaccines using WHO International Standard